At any given time, approximately 900 research studies and clinical trials are occurring at Greenville Health System (GHS) in various areas.
Research and Clinical Trial Areas
- Pediatric Oncology
- Women’s health
- Cardiology Vascular Disease
Clinical trials are structured research studies conducted to answer specific questions concerning new therapies, medications, medical devices, vaccines or new ways of using existing treatment. Trials are sponsored or funded by a variety of organizations from federal agencies to physicians, medical institutions, foundations and pharmaceutical or medical device companies.
This innovative research often results in medical breakthroughs and gives our patients access to the latest treatments, therapies and medications.
In addition to clinical research, GHS also participates in applied basic science to support the development of new medical devices and drug therapies in the areas of oncology, reproductive endocrinology and vascular surgery.
The consent form that you receive when you are invited to be a research subject includes some contact information if you have questions or concerns about the study.
You may contact a representative of the Institutional Review Board (IRB) of GHS for information regarding your rights as a participant involved in a research. You may obtain the name and number of this person by calling (864) 455-8997. Questions and concerns for IRB may include:
- Research study(s)
- Research-related risks or injuries
The GHS Office of Human Research Protection (GHS OHRP), Institutional Review Board (IRB) and GHS want to meet their primary responsibility of protecting human subjects who participate in research at GHS. We also want to work in a cooperative and collegial manner with investigators at GHS to assure this protection as a team.
Unfortunately, sometimes the best of intent does not always yield the best of results. If you have concerns or complaints about the service you received from the GHS OHRP or one of the IRBs, you have been unable to resolve the problem after direct communication with the GHS OHRP Medical Director, or the IRB, investigators may address concerns and/or suggestions by submitting a written document to the Institutional Official at:
Spence Taylor, MD
Vice President of Physician Engagement
President & Chief Academic Officer
GHS Health Sciences Center
The Institutional Official may respond verbally, or in writing and may take such action as needed to address the concerns or suggestions.